Results 11 to 20 of about 89 (82)

The use of atypical antipsychotics in the therapy of depressive episodes in patients with bipolar disorder [PDF]

open access: yes, 2021
This literature review addresses the effi cacy and safety of atypical antipsychotics in patients with bipolar depression. Th e results of randomized studies and systematic meta-analyses of recent years were revised in detail.
E. A. Strel’tsov
core   +2 more sources

Metabolic adverse effects of antipsychotics: the state of the problem and management options [PDF]

open access: yes, 2023
Antipsychotic  drugs are widely used for many psychiatric disorders, such as schizophrenia, bipolar affective disorder, delusions and hallucinations  due to neurological  disorders, depression with severe psychotic  symptoms.
A. V. Balashova   +3 more
core   +2 more sources

Possibilities for the use of hydroxychloroquine for pre- and postexposure prophylaxis of SARS-CoV-2 infection among exposed contacts and healthcare personnel [PDF]

open access: yes, 2020
There currently exists no published robust data which would confirm effectiveness and safety of hydroxychloroquine in pre- and postexposure prophylaxis of SARS-CoV-2 infection.
A. V. Krykov   +2 more
core   +2 more sources

Cognitive impairments in schizophrenia and their impact on oxidative stress [PDF]

open access: yes, 2022
The article is devoted to modern concepts of cognitive disorders in schizophrenia. Neurocognitive deficits can be expressed in impaired attention, auditory memory, motor skills, working memory, processing speed and executive function.
A. S. Piatoikina   +2 more
core   +3 more sources

Psychopharmacotherapy of Suicidal Behavior in Schizophrenia and Schizophrenic Spectrum Disorders [PDF]

open access: yes, 2020
Background. Suicidal behavior in schizophrenia correlates with the severity of productive and negative personality symptoms.Aims. Study of the clinic, the effectiveness of psychopharmacotherapy of paranoid schizophrenia and schizotypal disorder with the ...
L. A. Ivanova
core   +2 more sources

Evaluation of the influence of antipsychotics on bone metabolism and characteristics of the body composition in patients with schizophrenia [PDF]

open access: yes, 2023
Uvod: Podaci iz literature pokazuju da terapija antipsihoticima može da utiče na koštani metabolizam kod pacijenata sa shizofrenijom. Cilj: Naš cilj je bio da utvrdimo uticaj različitih antipsihotika na metabolizam kostiju, mineralnu koštanu gustinu i ...
Korićanac, Aleksandra P.
core  

CAN MELATONIN BE EFFECTIVELY USED TO DIMINISH SIDE EFFECTS OF VARIOUS PSYCHOTROPIC DRUGS AND ELECTROCONVULSIVE THERAPY? [PDF]

open access: yes, 2017
Цель исследования. Изучить и обобщить имеющуюся доказательную базу для применения мелатонина в качестве корректора побочных эффектов психотропных лекарств и электросудорожной терапии, и представить читателю соответствующие выводы.Методология проведения ...
Bekker, Roman Aleksandrovich   +2 more
core   +3 more sources

Аналітичний огляд побічної дії та летальних наслідків гострих отруєнь нейролептиками та антидепресантами [PDF]

open access: yes, 2020
Topicality. Increase in the use of antipsychotics and antidepressants in many countries led to augmentation of acute poisoning amount with lethal cases.
Kucher, T.   +3 more
core   +2 more sources

СТРАТЕГІЯ ТА ПРИНЦИПИ ТЕРАПІЇ ПАЦІЄНТІВ ІЗ ШИЗОФРЕНІЄЮ І КОМОРБІДНИМИ СЕРЦЕВО-СУДИННИМИ ЗАХВОРЮВАННЯМИ [PDF]

open access: yes, 2019
Коморбідність психічних розладів із соматичною патологією являє собою одну з провідних та надскладних проблем сучасної психіатричної практики, зокрема в питаннях терапії.
Ye. V. Opryа
core   +2 more sources

Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) [PDF]

open access: yes, 2019
The article presents the results of screening data from a simultaneous study of 443 outpatient cards of patients with schizophrenic spectrum disorders who were under dynamic outpatient monitoring in two areas of the psycho-neurological dispensary No.
A. V. Litvinov   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy